Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what was the total allocation of funding from the Life Science Innovative Manufacturing Fund to projects aimed at improving the (a) supply and (b) distribution of pancreatic enzyme replacement therapy since 2 March 2022.

The Life Sciences Innovative Manufacturing Fund has – since its inception in March 2022 – supported a wide range of projects across the life sciences sector, able to manufacture different types of life-saving medicines and medical devices. Several of these could have the capability to manufacture medicines such as pancreatic enzyme replacement therapies. The latest iteration of this fund will allocate up to £520 million to deliver economic growth and build health resilience. The fund is currently open to applications, and we encourage companies with eligible life sciences manufacturing projects to apply.